Child outcomes after prenatal progesterone for prevention of preterm birth, follow-up of the AMPHIA trial

Long-term follow-up of children exposed in-utero to progesterone for prevention of preterm birth: follow-up of the AMPHIA trial

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON27515

Enrollment

300

Registered

2020-09-29

Start date

2020-09-29

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prevention of preterm birth in multiple pregnancy

Interventions

Progesterone

Eligibility

Inclusion criteria

Inclusion criteria: The study population consists of all women that participated in the AMPHIA trial (n=671) and their children (n=1355) between 11-14 years of age.

Exclusion criteria

Exclusion criteria: Not able to read and speak Dutch and therefore not able to give informed consent and fill out questionnaires for this follow-up study.

Design outcomes

Primary

Measure	Time frame
Cognition and behavior of the offspring.	—

Secondary

Measure	Time frame
Death (perinatal and death up to 14 years of age), gender identity and health related problems (including information on surgery, hospital admission and medication use). Educational performance at the end of primary school for all children born to women who participated in the AMPHIA trial (regardless of participation in follow-up).	—

Contacts

Public ContactEmilie van Limburg Stirum

Amsterdam UMC - location AMC

amphia-fu@amsterdamumc.nl003120566740

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)